PhysIQ announced today that it will collaborate with CellCarta to undertake a study using AI in vaccine development. Enrollment is now complete in the VIII (Vaccine-induced inflammation investigation), which will monitor individual differences in physiologic changes associated with immune system activation in patients receiving vaccinations, including those developed to combat diseases like COVID-19. According to…